Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EID3 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of EID3 mRNA | CTD | PMID:27840820 | 17beta-estradiol | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of EID3 mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EID3 mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Eid3 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EID3 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Eid3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of EID3 mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EID3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EID3 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EID3 mRNA | CTD | PMID:28628672 | 4-hydroxynon-2-enal | increases expression | ISO | Eid3 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of EID3 mRNA | CTD | PMID:19191707 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of EID3 mRNA | CTD | PMID:30047161 | acrylamide | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of EID3 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | EID3 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of EID3 protein | CTD | PMID:20106945 | all-trans-retinoic acid | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of EID3 mRNA | CTD | PMID:33167477 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of EID3 mRNA | CTD | PMID:30047161 | andrographolide | multiple interactions | ISO | Eid3 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of EID3 mRNA | CTD | PMID:19737545 | aristolochic acid A | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of EID3 mRNA | CTD | PMID:33212167 | azathioprine | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of EID3 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of EID3 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | increases methylation | ISO | EID3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of EID3 exon | CTD | PMID:27901495 | beta-naphthoflavone | multiple interactions | ISO | Eid3 (Mus musculus) | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of EID3 mRNA | CTD | PMID:19737545 | beta-naphthoflavone | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of EID3 mRNA | CTD | PMID:32858204 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | EID3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of EID3 mRNA | CTD | PMID:31163220 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of EID3 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EID3 mRNA | CTD | PMID:28628672 | buta-1,3-diene | increases expression | ISO | Eid3 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of EID3 mRNA | CTD | PMID:29038090 | cobalt dichloride | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of EID3 mRNA | CTD | PMID:22941251 | copper(II) sulfate | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of EID3 mRNA | CTD | PMID:19549813 | crotonaldehyde | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | 2-butenal results in increased expression of EID3 mRNA | CTD | PMID:20471460 | cyclosporin A | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of EID3 mRNA | CTD | PMID:20106945 | dexamethasone | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EID3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EID3 mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | fluoranthene | multiple interactions | ISO | Eid3 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of EID3 mRNA | CTD | PMID:28329830 | formaldehyde | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of EID3 mRNA | CTD | PMID:20655997 | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of EID3 mRNA | CTD | PMID:24915197 | hydroquinone | decreases expression | ISO | EID3 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of EID3 mRNA | CTD | PMID:31256213 | indometacin | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EID3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EID3 mRNA | CTD | PMID:28628672 | iron dichloride | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | ferrous chloride results in increased expression of EID3 mRNA | CTD | PMID:35984750 | lipopolysaccharide | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of EID3 mRNA | CTD | PMID:35811015 | mercury dibromide | decreases expression | ISO | EID3 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of EID3 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EID3 mRNA | CTD | PMID:27188386 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EID3 mRNA | CTD | PMID:28801915 | p-chloromercuribenzoic acid | decreases expression | ISO | EID3 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of EID3 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EID3 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Eid3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of EID3 mRNA | CTD | PMID:17562736 | potassium dichromate | increases expression | ISO | Eid3 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of EID3 mRNA | CTD | PMID:23608068 | quercetin | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of EID3 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | EID3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Silver results in increased expression of EID3 mRNA | CTD | PMID:26014281 | silver(0) | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Silver results in increased expression of EID3 mRNA | CTD | PMID:26014281 | sodium arsenite | increases stability | ISO | EID3 (Homo sapiens) | 6480464 | sodium arsenite results in increased stability of EID3 mRNA | CTD | PMID:25493608 | sulforaphane | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of EID3 mRNA | CTD | PMID:31838189 | sunitinib | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of EID3 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of EID3 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EID3 mRNA] | CTD | PMID:31150632 | titanium dioxide | increases expression | ISO | Eid3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of EID3 mRNA | CTD | PMID:29264374 | trichostatin A | decreases expression | ISO | EID3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of EID3 mRNA | CTD | PMID:24935251 | urethane | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Urethane results in increased expression of EID3 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Eid3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of EID3 mRNA | CTD | PMID:17292431 and PMID:17963808 | valproic acid | increases expression | ISO | EID3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of EID3 mRNA | CTD | PMID:28001369 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of EID3 mRNA | CTD | PMID:23869203 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of EID3 mRNA | CTD | PMID:23034163 | |